TY - JOUR
T1 - Combined Beta-Adrenergic and Calcium-Entry Blockade in Angina Pectoris
AU - Packer, M.
PY - 1989/3/16
Y1 - 1989/3/16
N2 - THE combination of beta-adrenergic-blocking and calcium-entry–blocking drugs has achieved widespread popularity in the care of patients with angina pectoris. Combined therapy is frequently used to decrease the number and severity of anginal attacks in patients who remain symptomatic during treatment with a single agent. Low doses of two drugs are commonly prescribed instead of high doses of one agent, in the expectation that symptoms will be similarly controlled, but with fewer side effects. Antianginal drugs may also be combined in patients without symptoms in an effort to achieve maximal suppression of myocardial ischemia, in the hope that such suppression will…
AB - THE combination of beta-adrenergic-blocking and calcium-entry–blocking drugs has achieved widespread popularity in the care of patients with angina pectoris. Combined therapy is frequently used to decrease the number and severity of anginal attacks in patients who remain symptomatic during treatment with a single agent. Low doses of two drugs are commonly prescribed instead of high doses of one agent, in the expectation that symptoms will be similarly controlled, but with fewer side effects. Antianginal drugs may also be combined in patients without symptoms in an effort to achieve maximal suppression of myocardial ischemia, in the hope that such suppression will…
UR - http://www.scopus.com/inward/record.url?scp=0024972124&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024972124&partnerID=8YFLogxK
U2 - 10.1056/NEJM198903163201107
DO - 10.1056/NEJM198903163201107
M3 - Review article
C2 - 2564164
AN - SCOPUS:0024972124
SN - 0028-4793
VL - 320
SP - 709
EP - 718
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 11
ER -